Theremia

Solution

At Theremia, we build an AI-powered solution for drug optimization, starting with neurology and psychiatry.

NewPharmacological insights that predict where your asset is most likely to work, before you commit the spend.See how it works

Our Technology

We are pioneering a new approach to precision medicine in neurology and psychiatry by providing deep insights into patient response and treatment optimisation.

Theremia icon
Identify subgroups of responders

Our AI-driven models help detect key patient subgroups for whom a drug may be more or less effective, enabling personalized treatment strategies.

Theremia icon
Provide pharmacological insights

We provide scientific insights into drug differences in effectiveness and safety across multiple scales (phenotypic, molecular…)

Theremia icon
Create optimized version of drugs

We optimize pharmacological parameters for specific subgroups (dosage, galenic form, routes of administration, combinations)

Unique access to over 1 million high-quality individual patient data

Theremia has a unique access to high quality granular and longitudinal patient database and interdisciplinary knowledge

NACCInstitut du Cerveau ICMParkinson's Progression Markers InitiativeCPPMassachusetts General Hospital

Interdisciplinary team expertise multi-scale algorithm validated with practitioners across prospective cohorts

ChemistryChemistry
Molecular pharmacologyMolecular pharmacology
ModelingModeling
PhysiopathologyPhysiopathology
NeurosciencesNeurosciences

Meet our experts

Pipeline

We are building a scalable technology to reach the whole CNS diseases

Theremia

Contact us

[email protected]

Theremia